Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

Dengue FeverDengue Hemorrhagic FeverDiphtheriaPertussisTetanus

Phase 3

Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old

CompletedNCT02089347

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Pertussis, Tetanus

Start: 2014-03-31End: 2015-03-31Updated: 2017-05-30

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

TerminatedNCT02992418

Sanofi Pasteur, a Sanofi CompanyDengue Fever, Dengue Hemorrhagic Fever

Start: 2016-12-19End: 2019-12-10Updated: 2022-03-25

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

TerminatedNCT02992418

Sanofi Pasteur, a Sanofi CompanyDengue Fever, Dengue Hemorrhagic Fever

Start: 2016-12-19End: 2019-12-10Updated: 2022-03-25

Related Papers

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine

The Pediatric Infectious Disease Journal2021-06-103 citations